Pharmaceutical Processing predicts the market for fibromyalgia drugs will grow to 1.9 billion dollars a year by the 2023. The basis for their predictions are the introduction of generics for currently approved FDA drugs for FM and the introduction of four "new" drugs; two of which are reformulations Read more [...]
"I just try and not think about it, because it gets me furious" multiple sclerosis patient
The story sounds eerily similar. Citing questions regarding study quality and side effects, the FDA refuses to approve a drug for a condition for which few or no effective drugs exist. After hearing Read more [...]
Into the Big Leagues
Low dose naltrexone (LDN) is able to do for some people with intractable pain what opioids and other drugs can't do - reduce the pain. Those drugs have something LDN doesn’t, however, – FDA approval.
You can’t prove that LDN works, however, until you can identify Read more [...]
The microglia surround and protect the neurons in our brains and spinal cord. As the main immune defenders in the brain, they spew out an array of inflammatory and neurotoxic substances when activated. When we have a cold these substances cause the symptoms associated with ‘sickness behavior’ Read more [...]
A 'Novel' Anti-inflammatory
"We discuss the concept of using low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain conditions that are suspected to be associated with inflammatory processes."
Low dose Naltrexone is one of the more intriguing treatment options to emerge Read more [...]
"We ...feel this is a real game changer" Dr. Pridgen
With 90% of the data from their big Fibromyalgia antiviral study in, Dr. William "Skip" Pridgen reported in the Tuscaloosa News that the results were 'very positive'. Pridgen enthusiastically stated, "We feel we are on the right track and feel Read more [...]
Depression is common in fibromyalgia. In fact, with studies suggesting levels of 'current depression range from 22-44% and lifetime rates of depression from 60-86%,depression in FM may be very common. This isn't surprising: the presence of pain in any disorder increases the risk of depression Read more [...]
Chimerix, the manufacturer of the herpesvirus drug, brincidofovir (formerly known as CMX001), recently went public and the guess is that they're very confident about getting FDA approval. On your alternative treatments page you note brincidofovir appears to be 100x's more powerful that Read more [...]